Systematic Review on Xuezhikang in the Treatment of Type 2 Diabetes with Hyperlipoidemia
- VernacularTitle:血脂康治疗2型糖尿病高血脂症的系统评价
- Author:
Mei ZHAN
;
Bin WU
;
Ruming LIU
;
Yao TANG
- Publication Type:Journal Article
- Keywords:
Xuezhikang;
Type 2 diabetes;
Hyperlipoidemia;
Systematic review;
Meta-analysis
- From:
China Pharmacy
2001;0(12):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE: To evaluate the efficacy of Xuezhikang in the treatment of type 2 diabetes with hyperlipoidemia. METHODS: Retrieved from Cochrane Library, PubMed, EMBASE, CBM, VIP and CNKI databases and related periodicals, included randomized controlled trails (RCTs) was evaluated in quality. Meta-analysis was conducted with RevMan 5.0 software. RESULTS: The meta-analysis of 6 included RCT showed that the improvement of TC, TG, LDL-C, HDL-C, FBS, 2 h-BS, HbA1c, UAE in trial group were different from control group. There was statistical significance in difference between 2 groups. CONCLUSION: Routine glycemic control combined with Xuezhikang has better effect than routine glycemic control in the treatment of type 2 diabetes with hyperlipoidemia. Because the number and quality of included study are not satisfactory, the study result should be confirmed by randomized double-blind controlled trial.
